April 18, 2025

Mirco Friedrich: Forbes-List “30 Under 30 Europe”

Mirco Friedrich: Forbes-List “30 Under 30 Europe”

Mirco Julian Friedrich from the DKFZ, HI-STEM* and Heidelberg University Hospital (UKHD) was included in the renowned Forbes ‘30 Under 30 Europe’ list in the Science & Healthcare category.

The physician and cancer researcher, who has headed the Haematology and Immune Engineering junior research group since this year, initially developed successful approaches to reactivate the immune system against brain tumours.

With his current research, Friedrich aims to develop innovative strategies to reprogramme the human immune system by integrating synthetic immunology, genome editing and AI-controlled bioengineering. The aim is to prevent cancer, strengthen immune resilience and promote healthy ageing.

With this award, the US business magazine Forbes annually recognises outstanding young personalities under the age of 30 who stand out in their fields through their innovative strength, social relevance and exceptional achievements.


*The Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) gGmbH was founded in 2008 as a public-private partnership between the DKFZ and the Dietmar Hopp Foundation.

Our latest News

discover more
Strategic alliance for rare diseases: RHEACELL and AOP Health enter into strategic partnership to commercialize novel somatic cell therapies in Europe

Strategic alliance for rare diseases: RHEACELL and AOP Health enter into strategic partnership to commercialize novel somatic cell therapies in Europe

Heidelberg/Germany, May 27, 2025. RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will commercialize RHEACELL’s two stem cell products, EBESANAR® and AMESANAR®, in Europe, Turkey, Israel and the MENA region (Middle East and Northern Africa). RHEACELL retains full commercialization rights to EBESANAR® and AMESANAR® in […]

Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators. In a […]

Excellence Strategy: HITS researchers successful with two clusters on astrophysics and life sciences

Excellence Strategy: HITS researchers successful with two clusters on astrophysics and life sciences

How do stellar explosions or the evolution of galaxies influence our universe today? How can synthetic biology and specially designed cells aid in the protection of our immune system against infections and cancer? Tackling these research questions from different disciplines is the endeavor of two projects that have been selected as Clusters of Excellence in the […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp